Ογκολογία Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775 01/06/2023 time to read 2 min read
Ογκολογία Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial 01/04/2023 time to read 3 min read
Εμβόλια Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review Authors: Wei Vivian Wang et al. 21/12/2022 time to read 2 min read
Εμβόλια Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis 03/08/2022 time to read 3 min read
Ογκολογία Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer Authors: Peter Schmid et al. 10/02/2022 time to read 2 min read
Ογκολογία Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer Authors: Vicky Makker et al. 03/02/2022 time to read 2 min read
Ογκολογία Pembrolizumab vs placebo + chemotherapy as neoadjuvant treatment, followed by pembrolizumab vs placebo as adjuvant treatment for early triple-negative breast cancer (TNBC): Phase 3 KEYNOTE-522 study 01/02/2022 time to read 3 min read
Ογκολογία Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer Authors: Nicoletta Colombo et al. 11/11/2021 time to read 2 min read
Ογκολογία Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial Authors: Javier Cortes et al. 05/12/2020 time to read 3 min read
Ογκολογία Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer 27/02/2020 time to read 2 min read
Ογκολογία Pembrolizumab for Early Triple-Negative Breast Cancer Authors: Peter Schmid et al. 27/02/2020 time to read 2 min read